CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
✉ Email this page to a colleague
All Clinical Trials for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00160394 ↗ | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris | Completed | GlaxoSmithKline | Phase 4 | 2004-12-01 | Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity. |
| NCT00160394 ↗ | Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris | Completed | Stiefel, a GSK Company | Phase 4 | 2004-12-01 | Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to moderate severity. |
| NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Acronet | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
| NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Bellsystem24 , Inc. | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
| NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Mitsubishi Kagaku Bio-Clinical Laboratories, inc | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
| NCT00219570 ↗ | Dalacin-T Gel Post Approval Study | Completed | Parexel | Phase 4 | 2005-01-01 | To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify the clinical positioning of Dalacin T Gel. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Condition Name
| Condition Name for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% | |
| Intervention | Trials |
| Acne Vulgaris | 18 |
| BACTERIAL VAGINOSIS | 3 |
| Acne | 2 |
| Vulvovaginal Inflammation (Objective): Absent, Mild, Moderate, or Severe. | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Trials by Country
Clinical Trial Progress for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Clinical Trial Phase
Clinical Trial Sponsors for CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
Sponsor Name
